INTRODUCTION
The 1918 ''Spanish'' influenza pandemic killed more than 600,000 people in the United States and an estimated 40 million individuals worldwide. Infections by this H1N1 influenza A strain is thought to induce acute respiratory distress syndrome (ARDS) marked by a rapid onset of pneumonia, diffuse alveolar damage and associated hypoxemia, and a massive elevation in inflammatory cytokines (Berthiaume et al., 1999; Matuschak and Lechner, 2010; Ramsey and Kumar, 2011) . In recent analyses of influenza pandemics, death was often associated with bacterial coinfections, multiple organ failure, and widespread viral antigen expression in and damage to alveolar as well as to tracheal, bronchial, and bronchiolar epithelia (Lowy, 2003; Nakajima et al., 2011; Wu et al., 2011) . While the terminal pathology of H1N1 influenza and other causes of ARDS is becoming clear, we know less about what role regenerative processes play in recovery from ARDS. Clearly ARDS patients show improved lung function six to twelve months out, but for some both pulmonary and extrapulmonary deficits remain in the longer term (Herridge et al., 2003) . How much of the observed improvement in these patients is actually regeneration versus adaptive remodeling remains an area of intense study. Presumably regenerative processes in the airways involve local stem cell populations. Bronchioalveolar stem cells, or BASCs, which express both Clara cell markers (CC10) as well as alveolar type II (AT2) cell markers (SPC), have been described at terminal bronchioles and are proposed to be stem cells for both the bronchiolar as well as the alveolar epithelia (Giangreco et al., 2002; Kim et al., 2005) . However, lineage tracing of Scgb1a1+ (CC10) Clara cells demonstrate their role as progenitors in the repair of terminal bronchiolar epithelium but not of the alveolar epithelium ). In addition, BASCs lack precise cellular and molecular profiles and may consist of multiple stem cell types with different lineage commitment. For the upper airways, basal cells expressing the stratified epithelial stem cell transcription factor p63 (Yang et al., 1998; Yang et al., 1999; Senoo et al., 2007) have been implicated in regeneration of the tracheobronchial epithelium (Stripp and Reynolds, 2008; Rock et al., 2009; Giangreco et al., 2009; Rock et al., 2010; Cole et al., 2010) .
Whether stem cells for alveolar epithelia also exist in mice and participate in lung regeneration following damage is unknown. Models of lung damage in mice have yet to provide clear evidence for the existence of alveolar regeneration mechanisms. The most common lung injury model involves exposure to bleomycin, which results in widespread bronchiolar and alveolar damage. However, the invariable consequence of bleomycin treatment is parenchymal fibrosis rather than de novo alveolar assembly (Moore and Hogaboam, 2008; Hoshino et al., 2009 ). The successful adaptation of highly pathogenic human influenza A viruses to mice offers potential insights into both infectious disease and more nuanced models for recovery from ARDS (Mori et al., 1995; Gubareva et al., 1998; Gao et al., 1999; Lu et al., 1999; Belser et al., 2009 ). For instance, sublethal doses of a murine-adapted H1N1 (PR8) influenza A induces widespread damage to both upper and lower airways marked by epithelial destruction and immune cell infiltrates between four and 14 days post infection (dpi). Remarkably, these mice show viral clearing by eight dpi and a histologically complete recovery of lung tissue over the next several months (Narasaraju et al., 2010) . Understanding the extent and molecular sequence of alveolar regeneration and the role of progenitors and stem cells Figure S1 and Figure S2 .
in this process will direct future efforts toward therapeutically enhancing lung regeneration.
In this work, we examine the induction and recovery from an ARDS-like syndrome in mice infected with sublethal doses of a murine-adapted H1N1 influenza virus. We show that despite extensive damage to airway epithelial tissues, a p63-expressing population of cells in bronchioles undergoes a massive expansion and dispersion to sites of affected lung parenchyma. These migratory p63-expressing cells form discrete foci or ''pods'' that expand to a size and shape approximating those of alveoli and express genes linked to alveolar function. In parallel studies we clone three regiospecific stem cells from human airways and demonstrate that one of these, the distal airway stem cell (DASC), has the unique potential of differentiating to alveolar lineages. We discuss the possibility that these p63-expressing cells participate in alveolar assembly processes modeled by human DASCs in vitro, and therefore represent key features in lung regeneration in response to ARDS.
RESULTS

H1N1 Influenza Infection of Mouse Airways
Mice were infected with a murine-adapted H1N1 (PR8) influenza A by intratracheal aspiration at viral titers of 125 to 1x10 5 PFU to determine an LD 50 of approximately 500PFU. We chose 250PFU as a dose to induce significant damage without lethality in our experiments ( Figure 1A and Figures S1A and S1B available online). Lungs were harvested at multiple dpi and analyzed by histology and viral protein expression ( Figure 1B ). Viral load was estimated by monitoring the expression of the M2 viral ion channel protein by immunofluorescence, which revealed maximal staining at 4 dpi and a loss of M2 signal by 11 dpi (Figure 1B) . However, tissue damage, as measured by the degree of immune cell infiltration, appeared to peak at 11 dpi, was reduced at 21 dpi, and was largely cleared across the lung by 60 dpi (Figure 1B) . These results are mirrored by weight loss in these animals that reaches an extreme at 10-12 dpi and recovers by day 20 ( Figure S1C) . At the cellular level, we observed widespread destruction of all airway epithelial cells at 7 dpi resulting in a significant loss of markers for Clara cells (CC10) and ciliated cells (acetylated a-tubulin, TAp73) in the bronchiolar epithelia and AT2 cells (SPC+) of the alveolar epithelium ( Figure S1D ). Damage to airway epithelium is consistent with our observations of viral M2 expression in these cells at four days post-infection ( Figure S1E ). The peak of dense infiltrates of immune cells (CD45+) corresponds to the dense histological appearance of the lung at 11-14 dpi ( Figure S1F ). The H1N1 influenza-infected mice show widespread cytopathic effects and extreme weight loss, and yet both these effects are mitigated between 21-60 dpi. Remarkably, these mice recover without the acquisition of lung fibrosis that accompanies the induction of lung damage by bleomycin ( Figure S1G ), suggesting the possibility that epithelial regeneration underlies recovery from influenza.
Emergence of p63-Expressing Cells during Influenza Infection
Given the identification of p63-expressing basal cells as stem cells for nasal and tracheal epithelia of the upper airways (Rock et al., 2009) , we asked whether p63-expressing cells might also participate in lung regeneration following influenza infection. We found little evidence of p63-expressing basal cells in the bronchioles of normal mice. However, by 7 dpi, cells expressing p63 were evident in bronchioles (Figures S2A and S2B) . By 11 dpi, both p63 cells and Clara cells were found intermingled in the bronchiolar epithelium, and by 21 days most of the bronchiolar epithelium appeared restored at the level of Clara cells while those with p63-expression in the bronchioles were less evident. This rise and fall of p63 expressing cells is reflected in overall p63 protein expression in distal airways ( Figure S2C ). Unexpectedly, p63-expressing cells were also found in large numbers in the highly damaged lung parenchyma at 11 dpi (Figure 1C and Figure S2B) . On closer inspection, these p63-expressing cells in the damage lung appeared to be clustered in small groups ( Figure 1D ). Using other markers of basal cells, such as antibodies to keratin 5 (Krt5), it was evident that the p63-expressing cells formed discrete clusters or pods (hereafter ''Krt5 pods'') in interstitial lung ( Figure 1D) . On a gross level, Krt5 pods were distributed in a concentric pattern about bronchioles ( Figure 1E ). BrdU labeling of proliferating cells at 11 dpi revealed robust cell division of the Krt5+ cells in the bronchioles as well as in the Krt5 pods ( Figure 1F ). Direct quantification of BrdU+/Krt5+ cells revealed a progressive decrease in intrabronchiolar regions from 11 dpi and an increase in interbronchiolar regions from 11 dpi ( Figure S2D ). The appearance of Krt5+ pods in the peribronchiolar regions of lung parenchyma coincides with the pinnacle of influenza-induced lung damage. Significantly, Krt5+ pods were not observed in the bleomycin-dependent lung fibrosis model ( Figure S2E ).
Molecular Analysis of Human Clonogenic Airway Cells
To identify distal airway stem cells and assess their relationship to stem cells of the upper airways, we employed single cell cloning methods on populations of human epithelial cells derived from nasal turbinate, tracheobronchial epithelia, and distal airway tissue including bronchioles and alveoli (Rheinwald and Green, 1975; Barrandon and Green, 1987; Senoo et al., 2007) . We obtained immature colonies from approximately 1:500 to 1:2000 cells, and all of these stained uniformly for p63 and for keratin 5 (Krt5) (Figure 2A ). These immature clones were provisionally designated nasal epithelial stem cells (NESCs), tracheal airway stem cells (TASCs), and distal airway stem cells (DASCs). About 80 percent of these clones could be propagated further for at least an additional estimated 50 doublings while maintaining an immature phenotype (data not shown). Despite the fact that the original starting cell populations were obtained from disparate regions of the airways, the immature stem cell clones appeared indistinguishable by morphology and staining with basal cell markers. Significantly, gene expression datasets from these clones are binned in regiospecific group by unsupervised clustering and by PCA of the whole genome expression patterns despite sharing gene expression of approximately 99% of the 17,500 hybridizing genes ( Figures 2B and 2C ).
Pedigree Tracking of Airway Stem Cells
The long-term self-renewal potential of the putative human stem cell clones allowed us to isolate independent pedigrees for the analysis of the progeny of a single cell ( Figure 2D ). Expansion of these lines yielded abundant immature cells of known pedigree for a range of differentiation assays to assess lineage potential. For instance, we analyzed pedigree lines of NESCs and posted these through multiple differentiation assays. The air-liquid interface model (ALI; Schmidt et al., 1996) has been a powerful tool in airway epithelial differentiation and supports the differentiation of goblet cell and ciliated cells from immature populations of nasal epithelial cells. Significantly, all of our pedigree-defined lines of NESCs showed similar distributions of goblet cells and ciliated cells in ALI cultures ( Figure 2E ), supporting the concept that the pedigree lines we have developed from single cells in fact have lineage potential ascribed to NESCs. Whole genome expression analysis of immature, pedigree-defined lines and ALI-differentiated cells support this notion and showed an increased expression of genes involved in ciliogenesis (e.g., DYNLRB2, 22.73; TUBA4b, 9.83; and DNAH6, 7. 23; all p < 0.05) and in goblet cell function (e.g., MUC1, 3.83; MUC13, 5.63; and MUC20, 4 .513; all p < 0.05) ( Figure 2E ). We also performed self-assembling sphere (SAS) cultures of NESCs. SAS cultures, like the ALI cultures, induce both goblet cell and ciliated cell differentiation from NESCs, and involve the self-assembly of epithelial cells in conditions where cells cannot adhere to a solid support. NESC pedigrees readily assemble into spheres under such conditions within 24 hr, and efficiently undergo both goblet cell and ciliated cell differentiation over the following 15 days upon transfer to differentiation media ( Figure 2F ). Unlike the ALI cultures, which stratify into basal cells and suprabasal differentiated cells, the SAS cultures show a monolayer of ciliated cells and goblet cells polarized to the exterior and lack basal cells altogether (data not shown). Again, whole genome expression analysis supports the concept that SAS cultures promote ciliogenesis (e.g., increased expression of DYNLRB2, 68.43; DNAH7, 28.63; TEKT1, 25.13; all p < 0.05) and goblet cell formation (increased expression of MUC15, 6.73; MUC20, 7.63; SCGB2A1, 6.13; all p < 0.05) from our NESCs ( Figure 2F ). In contrast to their similar differentiation programs in ALI and SAS cultures, NESCs behaved very differently in 3-D Matrigel cultures. NESCs showed robust formation of solid spheres in Matrigel between days 5 and 10, which subsequently hollow with the addition of differentiation media, and by day 21 show immature cells at the periphery and cells with squamous differentiation toward the lumen (Figure 2G) . This squamous metaplasia is supported by the comparison between gene expression of undifferentiated NESCs and those differentiated for 21 days in Matrigel, which show strong expression of squamous epithelial genes (e.g., LCE2B, 173.13; KRT10, 6.03; and SPRR2A, 4.53; all p < 0.05) (Figure 2G) . Similar development of a squamous metaplasia has been seen with the differentiation of nasal turbinate epithelial cell populations, suggesting that our pedigree-defined cells retain the capacity for this pathway of differentiation. Overall gene expression PCA indicates that each of these differentiation assays yields different outcomes marked by a stratified airway epithelium in ALI cultures, a nonstratified airway epithelium in SAS cultures, and a squamous metaplasia in 3-D Matrigel cultures ( Figure 2H ).
DASC Pedigrees Assemble into Alveolar-like Structures In Vitro
Defined pedigrees of TASCs and DASCs were grown in ALI cultures to compare their differentiation potential with that of NESC lines. Like the NESC lines, the TASC pedigrees showed robust differentiation into ciliated cells and mucin-producing goblet cells during the 21 day period of ALI culture ( Figure 3A) . In contrast, the DASC pedigrees showed only minor indications of mucin expression, rare ciliated cell formation, and occasional CC10 expression indicative of Clara cells ( Figure S3A ). The TASC lines further differed from the DASC lines in their degree of stratification in ALI cultures. The TASCs presented a multilayered epithelium with p63-positive basal cells (data not shown) underneath differentiated goblet and ciliated cells, while the DASC pedigrees retain a monolayer appearance over the differentiation period ( Figure 3A) . Gene expression analysis of the ALI cultures of TASC and DASC lineages confirmed these observations, with the differentiated TASC cultures showing high expression of genes involved in ciliogenesis, mucin production, and epithelial stratification compared to DASCs grown in ALI culture ( Figure 3A) .
In 3-D Matrigel cultures, the TBEC lines, like the NESC pedigrees, underwent squamous metaplasia ( Figure 3B ). Curiously, the DASC pedigree lines also assemble into spheres but ultimately these hollow and collapse into multispherical structures by day 21 ( Figure 3B ). The hollowing effect appears to be the direct consequence of apoptosis as these cells within the spheres show robust activated caspase-3 staining (Figures S3B and S3C) . The multispherical entities formed from DASC lines do not stratify but appear to be comprised of unilaminar cellular assemblies that express the alveolar type 1 marker PDPN (Figure 3B) . These same structures are labeled with the 4C10 monoclonal antibody that recognizes a ca. 300 kDa protein specific to human alveoli ( Figure 3C) .
Consistent with the divergent differentiation of the TASC and DASC pedigrees in Matrigel cultures, datasets of whole genome microarrays of the structures assembled in 3-D cultures by these lines showed large differences ( Figure 3D ) including a host of genes implicated in alveolar structure or formation ( Figure 3E and Table S1 ). These findings were supported by wider Gene Set Enrichment Analysis (GSEA), which showed the squamous metaplasia of the TASC Matrigel structures expressed genes associated with epidermal development ( Figure 3F ). In contrast, the DASC-derived structures showed high expression of genes associated with angiogenesis regulation, monocation transport (Matthay et al., 2002; Eaton et al., 2009) , an important physiological function of AT1 cells, and synaptic transmission, a possible reflection of the importance of neurogenic control of alveolar function (Sakuma et al., 2006) .
Assembly of Alveoli-like Structures Conserved in Rodent-Derived DASC Pedigrees
To test whether similar p63-expressing stem cells could be derived from the deep lung of nonhuman species, we obtained multiple immature clones from distal airways of 3-week-old rats ( Figure 4A ). Defined pedigrees were developed from several of these that were subsequently grown in 3-D Matrigel cultures. All of the rat pedigree-specific DASC lines formed uniform solid spheres after 10 days of growth that subsequently hollowed over the next 11 days ( Figure 4A ). To determine whether these structures contain proteins linked to alveoli in vivo, we generated a panel of monoclonal antibodies from mice immunized to rat distal airway tissue ( Figures 4B and 4C ). Monoclonal antibodies 13A1 and 54D1 are specific to rat alveoli and recognize proteins with molecular masses of 45 and 25 kDa, respectively. These antibodies, which do not stain rat immature DASC clones, efficiently stain the unilaminar structures produced by the DASC pedigree lines ( Figure 4C ). These data suggest that these alveolar-like structures express genes found in alveoli. Further, the DASCs we describe here are fully committed to alveolar lineages with additional potential to form Clara, ciliated, and mucin producing cells and therefore distinct from the TASCs and NESCs that are committed to ciliated cells, goblet cells, and as well can undergo squamous metaplasia ( Figure 4D ). Despite these differences in lineage commitment, DASCs show only minor differences in gene expression compared with TASCs and NESCs in the range of 100-300 genes ( Figure 4E and Figure S4 ).
Influenza-Infected Lung Displays a Massive Increase in Clonogenic Basal Cells
To probe the basal-like cells observed in infected lung, we plated dissociated distal airway tissues in clonogenic assays ( Figure 5A, top panel) . The colonies that arose were uniform in appearance and were composed of small, p63-expressing immature cells and expressed Krt5 ( Figure 5A, top panel) . When grown in Matrigel cultures, cells from these colonies from solid spheres that hollow through cell death to yield unilaminar structures similar to those generated by human DASCs (cf. Figure 3B ). These unilaminar structures stain for antibodies to aquaporin 5 (Aqp5), a marker of alveoli ( Figure 5A, lower panel) . A comparison of expression performed on RNA amplified from individual clones and the Matrigel structures formed from them showed reproducible differences in gene expression ( Figure 5B ). The immaturity markers Krt5 and Krt14 are lost in during differentiation in Matrigel, while markers of alveoli, such as Aqp5 and surfactant proteins Sftpa1, Sftpb, and Sftpc, are all upregulated in these structures. Consistent with the appearance of large numbers of p63-positive cells in lung parenchyma following H1N1 influenza infection (cf. Figure 1) , we observed a several hundred-fold increase in clonogenic cells in infected lungs ( Figure 5C) . Whole genome microarray revealed reproducible differences in 358 genes among three clones from control and infected lungs ( Figure 5D) . One of the genes proved to be keratin 6A (Krt6a), a known marker of migrating keratinocytes during wound healing in the epidermis (Wojcik et al., 2000) . Expression of this gene alone differentiates between the clones derived from control lung and 12 dpi lung ( Figure 5E ). In vivo, Krt6 antibodies differentiate between basal-like cells in Krt5 pods of interstitial regions from basal cells of bronchioles whereas Krt5 antibodies recognize both these ectopic basal cells and those in the bronchiolar epithelium ( Figure 5F ). GSEA of the expression data sets derived from the distal airway colonies revealed a bias for genes involved in wound healing, tissue development, and regulation of growth in those from infected mice ( Figure 5G and Figure S5 ).
Are Krt5 Pods Linked to Lung Regeneration?
The ability of human distal airway stem cells to form alveoli-like structures in vitro made it tempting to predict that the Krt5 pods of basal-like cells seen in the influenza-damaged lung were components of a regenerative process. Consistent with this, the general appearance of individual Krt5 pods at 11 dpi was one of tight clusters of cells, while at 15 and 21 dpi many of these pods had lumens reminiscent of alveoli ( Figure 6A ). Direct quantification of these Krt5 pod ''types'' over time confirmed this notion, suggesting a progression over 10 days from a tight group of Krt5+ cells to structures resembling alveoli (Figure 6B) . We asked whether the Krt5 pods would stain with a new monoclonal antibody we generated from mice immunized with human fetal lung designated here as ''11B6.'' 11B6 reacts specifically to alveolar regions of mouse lung but not to bronchioles ( Figure 6C and Figure S6A ). Staining of regions of damaged lung containing Krt5 pods with the 11B6 monoclonal antibody revealed colocalization of the two antigens especially in those pods with larger diameters, suggesting a specificity for those Krt5 pods with larger lumens ( Figure 6C ). Quantification of this link between 11B6 and Krt5+ pods also correlated with dpi ( Figure 6D ). We also probed the Krt5 pods with antibodies to PDPN, which shows an alveoli-specific pattern in normal lung ( Figures 6B and 6E ). PDPN antibodies also colocalize with Krt5 pods ( Figure 6E) . (E) Venn diagram depicting differentially expressed genes between TASC and DASC stem cell pedigrees, while the graphics below indicate the absolute fold-change in gene expression between TASC and DASC among more than 17,000 informative genes. See also Figure S4 .
In assessing the influenza-infected lung from a panoramic view, we observed three distinct areas: normal appearing lung parenchyma with histologically normal alveoli, damaged regions marked by semi-dense infiltrate and Krt5 pods, and damaged regions marked by highly dense infiltrates but without Krt5 pods ( Figure S6C ). Krt5+ pods were never observed in regions of histologically normal lung tissue. The presence of Krt5 pods in less-densely infiltrated regions suggests that these regions are undergoing regenerative repair and clearing dense immune cell infiltrates in the process. Indeed the regions marked by Krt5+ pods show intermingled, CD45-positive immune cells in the immediate proximity ( Figure S6D ). We also noticed that within regions of dense infiltrate were bronchioles that lacked Krt5-positive basal cells, whereas bronchioles associated with satellite Krt5-positive pods also had Krt5-positive basal cells ( Figure 6F ). While speculative, this observation might reflect the possibility that if the infection eradicates the bronchiolar epithelium, it may be incapable of spawning a peribronchiolar population of Krt5 pods.
Krt5 Pods at Sites of Lung Regeneration
We used laser capture microdissection (LCM) to isolate RNA for expression microarray analysis from frozen sections of 25 dpi lung regions rich in Krt5 pods, normal or repaired lung, or regions of high-density infiltrates without obvious repair. The regions of high-density infiltrates without obvious alveoli were further divided into regions with and without SPC, a marker of alveolar type II cells ( Figure 7A ). PCA of these datasets revealed that the regions rich in Krt5 pods were most closely related to the regions of normal or repaired lung ( Figure 7A, inset) . This impression is reinforced by a heatmap of differentially expressed genes in these datasets which shows the similarity between the densely infiltrated regions devoid of alveolar markers and the densely infiltrated, SPC+ regions marked as Cluster D genes ( Figure 7B ). Cluster D genes include strong representations by immune cell functions and innate immune signaling consistent with the persistence of a dense infiltration of immune cells (Figure 7C and Table S2 ). In contrast, the regions with Krt5 pods show significant overlap with normal lung in a gene set designated Cluster B including genes involved with angiogenesis and endothelin signaling (Khimji and Rockey, 2010) , as well as aromatic amine degradation known to be functionally linked to lung endothelial cells (Gillis and Pitt, 1982) (Figure 7C and Table  S2) . Additionally, Cluster B shows an overrepresentation by genes involved in Wnt, Hedgehog, and nicotinic acetylcholine receptor signaling. Together, these data suggest that the Krt5 pods are in association with elements of endothelial cells involved in capillary formation. Moreover, Cluster B genes Figure S5 and Table S1 .
include an array of alveolar genes not expressed in regions of damaged lung lacking Krt5 pods (marked by the SPC+/ Krt5-or SPC-/Krt5-) ( Figure 7D and Table  S2 ), including PDPN, caveolin 2, Aqp5, and PDGFRa. Cluster C genes, those overrepresented only in regions of nondamaged lung, are characterized by gene sets associated with integrin signaling, angiogenesis, nicotinic acetylcholine receptor signaling, and axon guidance by semaphorins ( Figure 7C and Table S2 ). Consistent with the link between Krt5 pods and lung regeneration, we see robust colocalization of Krt5 and the alveolar-specific monoclonal antibody 11B6, but no 11B6 staining of damaged regions regardless of whether they have SPC staining ( Figure S7) . On the broadest level, these data support the notion that regions with Krt5 pods express genes similar to apparently normal or repaired lung, and very different from regions marked by severe damage. They also suggest a dynamic process involving a host of pathways whose significance for the recovery from ARDS will require extensive empirical validation.
Lineage Tracing of Alveolar Progenitors from Bronchioles to Alveoli
While clusters of Krt5+ pods always appear in a peribronchiolar pattern in influenza-infected lung about bronchioles with Krt5+ cells, their origins remained to be established. To test whether the Krt5 cells that appear in the bronchioles are indeed the origins of the parenchymal Krt5+ pods, we used standard lineage tracing methods based on Tamoxifen-dependent LacZ expression driven by Cre recombinase from the keratin 14 (Krt14) promoter (Mao et al., 1999; Vasioukhin et al., 1999) . Krt14-postive cells are not present in bronchioles prior to infection but become evident at 4 days post-infection as the same cells expressing Krt5 and increase in numbers through day 9 while remaining restricted to the bronchioles ( Figure 8A ). At or around 11 dpi, there appears to be a concerted migration of these Ktr5/Krt14 positive cells to interstitial lung and the appearance of Krt5 pods ( Figure 8A and Figure S8 ). Treatment of these mice with daily injections of Tamoxifen at 5, 6, and 7 dpi resulted in labeling of both the bronchioles and the Krt5+ pods at 25 dpi ( Figures 8B and 8C ). These data are consistent with the notion that the Krt5+ pods arise from cells that migrate from the bronchioles to local sites of interbronchiolar lung damage.
DISCUSSION
Recovery from lung damage that has advanced to ARDS is highly variable and poorly understood at present. Critical questions remain to understand the differential fates of ARDS patients, the potential of lung regeneration versus fibrosis, and whether therapies can sway clinical outcomes. In this work we addressed the recovery from ARDS in mice infected by H1N1 influenza. The histological evidence suggests a largely complete lung restoration several months following severe influenza infection (this study; Narasaraju et al., 2010) . In fact we show that, unlike bleomycin-induced ARDS, which invariably leads to fibrosis without evidence of regeneration (Moore and Hogaboam, 2008; Hoshino et al., 2009 ), mice recovering from influenza infections lack detectable lung fibrosis even following viral doses approaching the LD 50 . These data suggest that considerable regeneration of lung tissue, including complex alveolar-capillary networks, must be acting in this recovery. Indeed for the conducting, upper airways of mice, such as nasal passages, trachea, and bronchi, there are abundant data for regeneration after severe damage involving p63-expressing basal cells (Stripp and Reynolds, 2008; Rock et al., 2010) . Despite this progress in understanding stem cells of the conducting airways, definitive evidence for a stem cell that can See also Figure S7 and Table S2. contribute to lung regeneration has been more elusive. Bronchioalveolar stem cells, or BASCs (Kim et al., 2005) , have been a useful model for such stem cells but have not been cloned nor characterized beyond a limited marker set. More recently, a c-Kit-positive stem cell from the human airways expressing many markers of embryonic stem (ES) cells have been described to give rise to both epithelial and endothelial components of alveolar capillary complexes in xenograft experiments (Kajstura et al., 2011) . The stem cells we describe are fundamentally different from BASCs or the c-Kit, ES-like stem cells presented earlier and first drew our attention as massive numbers of p63-expressing cells in the damaged lung parenchyma at the height of influenza-induced damage. p63-expressing cells are not found in normal interstitial lung, and rarely even detected in normal bronchioles. However, p63 cells increase dramatically in bronchioles in the first several days of influenza infection, and appear in nearby damaged interstitial lung at 11 days post infection where they continue proliferation and assemble into pods. Remarkably, the number of clonogenic cells in the distal airways increases several hundred-fold within seven days of influenza infection, and these cells assume aspects of gene expression patterns seen in p63-expressing stem cells in the epidermis during wound repair. Pods containing these cells are almost always found in a radial pattern about a bronchiole that also has p63-expressing cells, and not about bronchioles that lack p63 cells. One interpretation of these data is that bronchi- oles are the source of these cells, a concept supported by our lineage tracing experiments with the Krt14-Cre/Rosa26-stop-LacZ mice. Our efforts to clone and characterize three regiospecific stem cells of the airways has provided a foundation for understanding the nature of the p63-expressing cells that comprise the Krt5 pods following influenza infection. The role of p63-expressing basal cells as stem cells for distal lung was largely discounted because they proved to be rare in the small bronchioles compared with the upper airways. Thus we were surprised with the ease by which we could generate immature clones of p63-expressing cells from populations of human distal airway epithelial cells. Despite the nearly 99% overlap in gene expression between DASCs and the upper airway TASCs and NESCs, DASCs displayed commitment to a unique program of differentiation that includes alveolar epithelium.
What is the evidence that these Krt5 pods are intermediates in alveolar regeneration of influenza-damaged lung, and not a pathogenic pathway akin to bronchiectasis? Part of the argument is a kinetic one, as 11 dpi Krt5 pods are solid spheres of cells that develop lumen and expand in size over the next 10 days to form alveoli-like structures. This hollowing and unilaminar appearance is strikingly similar in timing and appearance to the alveoli-like structures formed by human DASCs in 3-D cultures. These data were further supported by the costaining of the Krt5 pods with antibodies directed to antigens found exclusively in alveoli such as PDPN and the target of the 11B6 monoclonal antibody. Neither of these antibodies reacts with regions of influenza-damaged lung that lack Krt5 pods.
Perhaps the most intriguing evidence favoring a role for Krt5 pods in alveolar regeneration was the direct comparison of gene expression profiles of discrete regions of lung at 25 dpi. Four regions are evident in these lungs: (1) normal lung marked by ordered alveolar networks, (2) highly infiltrated zones without alveolar markers whatsoever, (3) zones of immune cell infiltration and disordered SPC staining, and (4) clusters of Krt5 pods showing intermediate infiltration. The expression microarray data revealed that the high-density regions (SPC+ or SPC-) showed similar patterns of gene expression marked by inflammation, innate immune functions, and B and T cell profiles. From these data, which are consistent with the high level of infiltration of both regions and the very low expression of alveolar markers such as PDPN or the 11B6 monoclonal antibody, it is likely that both regions are damaged and not undergoing active repair. Regions marked by clusters of Krt5 pods, in contrast, had gene expression profiles that showed significant overlap with those of normal regions of interstitial lung. Within the set of genes overlapping between the clusters of Krt5 pods and the normal lung were genes common to AT1 cells. Interestingly, Gene Ontology analysis showed that these overlapping genes contained genes involved in angiogenesis, endothelin signaling, and aromatic amine degradation, all processes or functions attributed to lung endothelial cells and the formation of new blood vessels. Thus regions occupied by Krt5 pods are likely associated with, in addition to AT1 cell markers, the initiation of new blood vessels. It is tempting to speculate that such angiogenesis is related to the need to bring capillary beds into direct contact with regenerating alveolar structures.
The study presented here leaves key questions unresolved. What, for instance, are the signals that trigger the proliferation and radiation of p63-expressing cells from bronchioles to sites of influenza-damaged lung? How do incipient alveolar structures assembled in damaged lung link up to the conducting airway? What are the mechanisms that merge microvasculature assemblies with the nascent alveoli? Why is SPC expression, a marker of AT2 cells, absent from the alveolar-like structures formed by the Krt5 pods? Answers to these questions, as well as those concerning the dynamics of alveolar assembly, will be essential for determining the kinetics and regulation of lung regeneration. The work presented here focuses on alveoli formation in what is likely to be the simplest aspect of lung regeneration ( Figure 8D ). How these incipient structures link up to the conducting airways as well as the pleural capillary network represents an immense challenge but one that is likely to generate new therapies for an array of presently incurable airway diseases.
EXPERIMENTAL PROCEDURES
Animal Models C57/Bl6 adult mice were infected with a sublethal dose of Influenza H1N1 A/PR/8/34 mouse adapted virus by intratracheal inhalation and lungs were harvested at various time points post infection. For BrdU incorporation assays 30 mg/kg BrdU in sterile PBS was administered IP. Bleomycin (6U/kg) treatment was by intratracheal administration. All procedures were conducted under IACUC guidelines and approved protocols.
Histology and Immunofluorescence
Mice were sacrificed and lungs were inflated and fixed with 4% formaldehyde prior to paraffin embedding. Antibodies included influenza virus A M2 protein (Abcam), p63 (4A4 clone), alveolar markers (13A1, 54D1, 4C10,11B6 clone), Krt5 (Neomarkers), Muc5Ac, CC10, SPC, Pdpn, Aqp5, Cd45 (Santa Cruz), BrdU (Accurate Chemical), p73 (3A6 clone), Ivl, Krt14, Krt10, Krt6 (Covance), pan-Keratin, SMA and acetylated alpha tubulin (Sigma). Murine monoclonal antibodies were generated to human 22 wk fetal lung tissue obtained under IRB approval using standard methods (Kö hler and Milstein, 1975) .
Microarray and Bioinformatics
RNAs obtained from LCM and colonies were amplified using the WT Pico RNA Amplification System, WT-Ovation Exon Module and Encore Biotin Module (NuGEN Technologies) and hybridized onto GeneChip Mouse Exon 1.0 ST Array. GeneChip operating software was used to process all the Cel files and calculate probe intensity values. To validate sample quality, probe hybridization ratios were calculated using Affymetrix Expression Console software.
The intensity values were log2-transformed and imported into the Partek Genomics Suite 6.5(beta). Exons were summarized to genes and a 1-way ANOVA was performed to identify differentially expressed genes. P values and fold-change were calculated for each analysis. Heatmaps were generated using Pearson's correlation and Ward's method and Principal Component Analysis was conducted using all probe sets. Pathway analyses were performed using Gene Set Enrichment Analysis (GSEA) software and PANTHER database (Subramanian et al., 2005) .
Cloning of Human, Rat, and Mouse Airway Stem Cells Human, rat, and mouse airway cells were cultivated onto a feeder layer of lethally irradiated 3T3-J2 cells in cFAD media and clonal analysis was based on previously described methods for epidermal stem cells (Barrandon and Green, 1987) . Human nasal epithelial cells were isolated from human inferior turbinate. Normal human tracheobronchial epithelial cells and human small airway epithelial cells were purchased from Lonza. Primary rat and mouse lung epithelial cells were isolated from 3-week-old Wistar rats and 3-to 12-week-old C57/B6 mice.
In Vitro Differentiation Assays for Human and Rat Cells
Air-liquid interface culture of nasal epithelial cells was performed as described (Schmidt et al., 1996) . Briefly, cells were cultured on Transwell plates (Corning). At confluence, the medium on the inserts was removed and the medium outside the insert was changed to differentiation medium (DMEM/F12 1:1, 50mg/ml penicillin; 50 mg/ml streptomycin; Fungizone 2.5 mg/ml (GIBCO); 10 ng/ml cholera toxin, retinoic acid 10 À7 M; 10% Knockout SR serum replacement (GIBCO)). Self-assembly sphere culture was performed as described in differentiation medium. The culture dishes were placed on an orbital shaker at 30-60 in an incubator at 37 C and 5% CO 2 .
3-D Matrigel assays were performed on chambered glass slides as described in mammary cell 3-D culture. Briefly, the cell suspensions were placed on Matrigel at 3 3 10 4 cells/chamber and differentiated with 20 days After 20 days culturing in the differentiation medium CnT-23(Cellntec) + 1mMCaCl 2 with 1% Matrigel, the 3-D structures fixed for sectioning and staining.
Mouse Stem Cell In Vitro Differentiation Assay
The dissociated cells from each lung were plated on irradiated J2-3T3 feeder layers in cFAD medium and then transferred to growth factor-reduced Matrigel (BD Biosciences) and cultured in growth medium (DMEM/F12, 1:1, 1% PenStrep, 10 mg/ml insulin, 5 mg/ml transferrin, 0.1 mg/ml cholera toxin, 25ng/ml EGF, 30 mg/ml BPE, 5%FBS, 50 ng/ml FGF10 and 30 ng/ml HGF for 4 days. Differentiation was induced until day 12 with differentiation medium (DMEM/ F12, 1:1, 1%penstrep, 5 mg/ml insulin, 5 mg/ml transferrin, 0.025 mg/ml cholera toxin, 5ng/ml EGF, 30 mg/ml BPE, 1mg/ml BSA, 50 ng/ml FGF10 and 30ng/ml HGF). Please see Extended Experimental Procedures for additional details.
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